LOC729083 Inhibitors belong to a specialized chemical class of compounds meticulously designed to interact with and modulate the activity of a unique and less characterized protein encoded by the LOC729083 gene. LOC729083 is a representative of the numerous "LOC" genes, which are often referred to as "predicted genes" with little known or annotated function. This particular protein's precise roles and functions within cellular processes remain largely undefined, making it an intriguing subject of scientific investigation. Inhibitors developed for LOC729083 are crafted with precision to selectively target this protein, offering researchers a powerful tool to probe the specific molecular and functional contributions of LOC729083 within cells.
The design of LOC729083 inhibitors focuses on their selectivity, ensuring that they exclusively interact with LOC729083 and do not interfere with other cellular components or processes. This selectivity is essential for researchers to gain deeper insights into the protein's functions and regulatory mechanisms without impacting other cellular functions. By employing LOC729083 inhibitors, scientists can embark on a journey to unravel the intricate web of interactions and processes in which LOC729083 participates, potentially uncovering its relevance to cellular homeostasis, signaling pathways, or other biological functions. While the exact role of LOC729083 in the cellular landscape is still an open question, the study of LOC729083 inhibitors opens new avenues for scientific exploration, offering a valuable tool for understanding the complexities of cellular biology and the potential contributions of lesser-known proteins to various biological processes.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $25.00 $117.00 $209.00 | 27 | |
Inhibits BCR-ABL kinase, used for CML. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
Inhibits multiple kinases, including RAF and VEGFR, for cancer therapy. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
Inhibits dihydrofolate reductase, employed in cancer and autoimmune disease. | ||||||
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $66.00 | 4 | |
Proton pump inhibitor, reduces gastric acid production for heartburn and ulcers. | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $256.00 | 18 | |
Antiestrogen, used for breast cancer by blocking estrogen receptors. | ||||||
Allopurinol | 315-30-0 | sc-207272 | 25 g | $128.00 | ||
Inhibits xanthine oxidase. | ||||||
Ibuprofen | 15687-27-1 | sc-200534 sc-200534A | 1 g 5 g | $52.00 $86.00 | 6 | |
Non-steroidal anti-inflammatory drug (NSAID) inhibiting COX enzymes to reduce pain and inflammation. | ||||||
Ritonavir | 155213-67-5 | sc-208310 | 10 mg | $122.00 | 7 | |
Protease inhibitor, used in HIV therapy by inhibiting viral protease enzymes. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $77.00 | 2 | |
Enhances insulin sensitivity and inhibits gluconeogenesis for type 2 diabetes management. | ||||||
Cimetidine | 51481-61-9 | sc-202996 sc-202996A | 5 g 10 g | $62.00 $86.00 | 1 | |
H2 receptor antagonist, reduces stomach acid production for ulcers and heartburn. | ||||||